Nathan J. Dowden, President & COO at Entrada Therapeutics, Inc. (TRDA), sold 1,826 shares at $12.32 ($22K) on 2024-03-06, disclosed to the SEC on 2024-03-08.
Scheduled sale ($22k) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |